Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Dapagliflozin in PRESERVED Ejection Fraction Heart Failure

ClinicalTrials.gov ID: NCT03030235

Public ClinicalTrials.gov record NCT03030235. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 4:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effects of Dapagliflozin on Biomarkers, Symptoms and Functional Status in Patients With PRESERVED Ejection Fraction Heart Failure

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to evaluate the impact of dapagliflozin, as compared with placebo, on heart failure, disease specific biomarkers, symptoms, health status and quality of life in patients with chronic heart failure with preserved systolic function.

Study identification

NCT ID
NCT03030235
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Saint Luke's Health System
Other
Enrollment
324 participants

Conditions and interventions

Eligibility (public fields only)

Age range
19 Years to 119 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2017
Primary completion
Aug 12, 2021
Completion
Aug 12, 2021
Last update posted
Oct 18, 2022

2017 – 2021

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
24
Facility City State ZIP Site status
Heart Group of the Eastern Shore Fairhope Alabama 36532
University of Southern California Los Angeles California 90032
First Coast Cardiovascular Institute Jacksonville Florida 32256
Charlotte Heart Group Research Center Port Charlotte Florida 33952
Emory University Atlanta Georgia 30303
NorthShore University HealthSystem Research Insititute Evanston Illinois 60201
Northwestern University Evanston Illinois 60208
Chicago Medical Research Hazel Crest Illinois 60429
OSF HealthCare Cardiovascular Institute Peoria Illinois 61606
St. Vincent Cardiovascular Research Institute Indianapolis Indiana 46260
Cotton O'Neil Clinical Research Center Topeka Kansas 66606
Johns Hopkins University Baltimore Maryland 21205
Massachusetts Hospital Boston Massachusetts 02114
Mayo Clinic Rochester Minnesota 55905
Saint Luke's Mid America Heart Institute Kansas City Missouri 64111
Washington University St Louis Missouri 63110
Columbia University New York New York 10032
St. Francis Hospital New York New York 11576
Eastern Nephrology Associates New Bern North Carolina 28562
Wake Forest University Winston-Salem North Carolina 27157
Oregon Health and Science University Portland Oregon 97239
Allegheny Health Network Research Institute Pittsburgh Pennsylvania 15212
Vanderbilt University Medical Center Nashville Tennessee 37232
Baylor Scott and White Research Institute Dallas Texas 75204
University of Utah Salt Lake City Utah 84112
Eastern Virginia Medical School Norfolk Virginia 23501

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03030235, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 18, 2022 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03030235 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →